Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome

Journal of Thoracic Oncology

Volumn 10, Issue 3, 2015, Pages 509-517

  Hoshimoto, Sojun ^a,b   Takeuchi, Hiroya ^b   Ono, Shigeshi ^a,b   Sim, Myung Shin ^a   Huynh, Jamie L ^a   Huang, Sharon K ^a   Marzese, Diego M ^a   Kitagawa, Yuko ^b   Hoon, Dave S B ^a  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RARB PROTEIN; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LONG INTERSPERSED REPEAT; MALE; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TUMOR GENE; CANCER STAGING; CASE CONTROL STUDY; COHORT ANALYSIS; COMPARATIVE STUDY; ESOPHAGUS; ESOPHAGUS TUMOR; FOLLOW UP; GENETICS; HUMAN GENOME; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; COHORT STUDIES; DNA; DNA METHYLATION; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; FOLLOW-UP STUDIES; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; HUMANS; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; SURVIVAL RATE;

EID: 84928382928     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000441     Document Type: Article

References (43)

1. Eslick GD, Epidemiology of esophageal cancer. Gastroenterol Clin North Am 2009 38 17 25, vii
2. Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M, Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 2000 232 225 232
3. Law S, Kwong DL, Kwok KF, Improvement in treatment results and long-Term survival of patients with esophageal cancer: Impact of chemoradiation and change in treatment strategy. Ann Surg 2003 238 339 347
4. Chao YK, Chan SC, Liu YH, Pretreatment T3-4 stage is an adverse prognostic factor in patients with esophageal squamous cell carcinoma who achieve pathological complete response following preoperative chemoradiotherapy. Ann Surg 2009 249 392 396
5. Yuequan J, Shifeng C, Bing Z, Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery. Ann Thorac Surg 2010 90 908 913
6. Guo W, Zhu T, Dong Z, Decreased expression and aberrant methylation of Gadd45G is associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma. Clin Exp Metastasis 2013 30 977 992
7. Zhu YH, Fu L, Chen L, Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma. Cancer Res 2013 73 2298 2309
8. Kamangar F, Chow WH, Abnet CC, Dawsey SM, Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009 38 27 57, vii
9. Bravi F, Edefonti V, Randi G, Dietary patterns and the risk of esophageal cancer. Ann Oncol 2012 23 765 770
10. Oka D, Yamashita S, Tomioka T, The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: A target for risk diagnosis and prevention of esophageal cancers. Cancer 2009 115 3412 3426
11. Sato F, Meltzer SJ, CpG island hypermethylation in progression of esophageal and gastric cancer. Cancer 2006 106 483 493
12. Jones PA, Baylin SB, The epigenomics of cancer. Cell 2007 128 683 692
13. de Maat MF, Narita N, Benard A, Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-Tumor loci in adenoma. Am J Pathol 2010 177 2347 2356
14. de Maat MF, Umetani N, Sunami E, Turner RR, Hoon DS, Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles. Mol Cancer Res 2007 5 461 471
15. Lander ES, Linton LM, Birren B, International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome. Nature 2001 409 860 921
16. Yang AS, Estécio MR, Doshi K, Kondo Y, Tajara EH, Issa JP, A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004 32 e38
17. Iwagami S, Baba Y, Watanabe M, LINE-1 hypomethylation is associated with a poor prognosis among patients with curatively resected esophageal squamous cell carcinoma. Ann Surg 2013 257 449 455
18. Shigaki H, Baba Y, Watanabe M, LINE-1 hypomethylation in gastric cancer, detected by bisulfite pyrosequencing, is associated with poor prognosis. Gastric Cancer 2013 16 480 487
19. Lee HS, Kim BH, Cho NY, Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma. Clin Cancer Res 2009 15 812 820
20. Sunami E, de Maat M, Vu A, Turner RR, Hoon DS, LINE-1 hypomethylation during primary colon cancer progression. PLoS One 2011 6 e18884
21. Kim YT, Park JY, Jeon YK, Aberrant promoter CpG island hypermethylation of the adenomatosis polyposis coli gene can serve as a good prognostic factor by affecting lymph node metastasis in squamous cell carcinoma of the esophagus. Dis Esophagus 2009 22 143 150
22. Kuroki T, Trapasso F, Yendamuri S, Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 2003 9 1441 1445
23. Long C, Yin B, Lu Q, Promoter hypermethylation of the RUNX3 gene in esophageal squamous cell carcinoma. Cancer Invest 2007 25 685 690
24. Wang Y, Fang MZ, Liao J, Hypermethylation-Associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma. Clin Cancer Res 2003 9 5257 5263
25. Fujiwara S, Noguchi T, Takeno S, Kimura Y, Fumoto S, Kawahara K, Hypermethylation of p16 gene promoter correlates with loss of p16 expression that results in poorer prognosis in esophageal squamous cell carcinomas. Dis Esophagus 2008 21 125 131
26. Zare M, Jazii FR, Alivand MR, Nasseri NK, Malekzadeh R, Yazdanbod M, Qualitative analysis of adenomatous polyposis coli promoter: Hypermethylation, engagement and effects on survival of patients with esophageal cancer in a high risk region of the world, a potential molecular marker. BMC Cancer 2009 9 24
27. Tonomoto Y, Tachibana M, Dhar DK, Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis. Oncology 2007 73 346 356
28. Hoshimoto S, Kuo CT, Chong KK, AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome. J Invest Dermatol 2012 132 1689 1697
29. de Maat MF, van de Velde CJ, van der Werff MP, Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence. J Clin Oncol 2008 26 2327 2335
30. de Maat MF, van de Velde CJ, Benard A, Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer. Clin Cancer Res 2010 16 2811 2818
31. TCGA Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008 455 1061 1068
32. Tanemura A, Terando AM, Sim MS, CpG island methylator phenotype predicts progression of malignant melanoma. Clin Cancer Res 2009 15 1801 1807
33. Umetani N, de Maat MF, Mori T, Takeuchi H, Hoon DS, Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase. Biochem Biophys Res Commun 2005 329 219 223
34. McShane LM, Altman DG, Sauerbrei W, Taube SE, Gion M, Clark GM, Statistics Subcommittee of the NCI-EORTC Working Group on Cancer Diagnostics Reporting recommendations for tumor marker prognostic studies (REMARK). J Natl Cancer Inst 2005 97 1180 1184
35. Saeed AI, Bhagabati NK, Braisted JC, TM4 microarray software suite. Methods Enzymol 2006 411 134 193
36. Murata A, Baba Y, Watanabe M, Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer. Br J Cancer 2013 109 408 415
37. Guo M, Ren J, House MG, Qi Y, Brock MV, Herman JG, Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus. Clin Cancer Res 2006 12 4515 4522
38. Kawakami K, Brabender J, Lord RV, Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000 92 1805 1811
39. Lo PH, Xie D, Chan KC, Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage. Cancer Lett 2007 257 199 205
40. Tepper J, Krasna MJ, Niedzwiecki D, Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008 26 1086 1092
41. Urschel JD, Vasan H, A meta-Analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003 185 538 543
42. Miyata H, Yamasaki M, Kurokawa Y, Multimodal treatment for resectable esophageal cancer. Gen Thorac Cardiovasc Surg 2011 59 461 466
43. Ando N, Kato H, Igaki H, A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol 2012 19 68 74